IP Verse

Compositions Comprising Glucagon Analogs And Methods Of Making And Using The Same - EP2694095B1

PatentPatent Analysis

EP2694095

LONGEVITY BIOTECH
Application Number
EP12768072A
Filing Date
Apr 5, 2012
Status
Revoked
Jul 3, 2020
Grant Date
Mar 7, 2018
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2694095B1 was granted to Longevity Biotech on Mar 7, 2018 following the initial filing on Apr 5, 2012 under the application number EP12768072A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ZEALAND PHARMADec 6, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents